DOJ Biogen Reaches $900 Million Settlement in False Claims Act Case Thomas Sullivan Aug 22, 2022 0 On July 20, 2022, Greene LLP announced that Biogen, Inc. reached an agreement to pay $900 million to resolve claims brought by a…
DOJ DOJ Announces $9.85 Million False Claims Act Settlement Over Above-Market… Thomas Sullivan Aug 19, 2022 0 On July 14, 2022, the United States Department of Justice (DOJ) announced a $9,853,958 settlement with BioReference Health LLC…
International Italian Sunshine Law Now in Force Thomas Sullivan Aug 18, 2022 0 On June 26, 2022, the so-called Italian Sunshine Act entered into force, cementing Law n. 62/2022 into law. The law establishes…
Compliance AdvaMed Code Changes Now Effective Thomas Sullivan Aug 17, 2022 0 On June 1, 2022, updates to the AdvaMed Code of Ethics on Interactions with Health Care Professionals (AdvaMed Code) became…
Telemedicine The Positive Impact of Telemedicine Thomas Sullivan Aug 16, 2022 0 Earlier this year, the Harvard Business Review (HBR) conducted an analysis of the way Kaiser Permanente and Intermountain…
HHS-OIG HHS OIG Reviews Prior Authorization Denials Thomas Sullivan Aug 15, 2022 0 Earlier this year, the Department of Health and Human Services Office of Inspector General (HHS OIG) issued a report focused on…
CME Independent Medical Education & Grants Summit 2022 Thomas Sullivan Aug 14, 2022 0 Independent Medical Education & Grants Summit Hybrid Event | September 20-22 in Philadelphia, PA Exclusive Offer – Be sure…
CME CME Updates on Metastatic Pancreatic Cancer Guidelines Live Webinar Series… Thomas Sullivan Aug 13, 2022 0 Metastatic pancreatic cancer is a serious malignancy that, with limited treatment options and poor outcomes, poses a growing…
Congress Are PBMs Next to be Regulated? Thomas Sullivan Aug 12, 2022 0 Politicians have long been discussing the cost of prescription drugs, advancing various policy proposals aimed at lowering drug…
CMS US Supreme Court Rejects Massive Cuts to 340B Hospitals Thomas Sullivan Aug 11, 2022 0 In June, the Supreme Court unanimously rejected massive payment cuts to hospitals under the 340B drug discount program. In the…